LIGAND PHARMACEUTICALS INC ($LGND)
Filing Information
| Accession Number | 0002001011-26-000049 |
|---|---|
| Form Type | 4 |
| Filing Date | May 15, 2026 |
| Document | View SEC Filing |
Transactions
11
Total Shares
6,569
Total Value
$704,462.97
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 1, 2026 | Sale | 80 | $227.37 | $18,189.40 | 42,173 | Direct | โ | View Details | |
Director | Common Stock | โ | May 1, 2026 | Sale | 1 | $229.87 | $229.87 | 42,172 | Direct | โ | View Details | |
Director | Common Stock | โ | May 1, 2026 | Sale | 165 | $231.87 | $38,258.07 | 42,007 | Direct | โ | View Details | |
Director | Common Stock | โ | May 1, 2026 | Sale | 105 | $232.57 | $24,419.89 | 41,902 | Direct | โ | View Details | |
Director | Common Stock | โ | May 1, 2026 | Sale | 116 | $234.09 | $27,153.89 | 41,786 | Direct | โ | View Details | |
Director | Common Stock | โ | May 12, 2026 | Exercise/Conversion | 459 | $69.51 | $31,905.09 | 42,245 | Direct | โ | View Details | |
Director | Common Stock | โ | May 12, 2026 | Sale | 459 | $224.00 | $102,816.00 | 41,786 | Direct | โ | View Details | |
Director | Common Stock | โ | May 13, 2026 | Exercise/Conversion | 1,575 | $69.51 | $109,478.25 | 43,361 | Direct | โ | View Details | |
Director | Common Stock | โ | May 13, 2026 | Sale | 1,575 | $223.50 | $352,012.50 | 41,786 | Direct | โ | View Details | |
Director | Non-Qualified Stock Option (right to buy) | Derivative | May 12, 2026 | Exercise/Conversion | 459 | $0.00 | $0.00 | 1,575 | Direct | โ | View Details | |
Director | Non-Qualified Stock Option (right to buy) | Derivative | May 13, 2026 | Exercise/Conversion | 1,575 | $0.00 | $0.00 | 0 | Direct | โ | View Details |